EfficientCME @EfficientCme

Aβ-targeting therapy for Alzheimer’s is both first in class and the first disease modifying strategy in the space. This microlearning program highlights 12 episodes of real questions from clinicians addressing the use of these agents in practice.  Link: lnkd.in/e7FFeRkf

Missed our live session at #RSNA2023? Catch the recording for a deep dive into the crucial role of #radiology in amyloid-related imaging abnormalities (#ARIA). Listen to experts and test your knowledge with case-based polling. Link: lnkd.in/eNfQDuCQ #MedicalImaging #CME

Case: 6-year-old with T21 and intractable LGS. Daily tonic, weekly tonic-clonic, rare atonic #seizures. Tried: ACTH, vigabatrin, dietary therapy, multiple ASMs. What would you do? Weigh in as Drs Sullivan, Kessler, and Perry walk through tough cases. Link: bit.ly/482msPl

Should antidepressants be considered for patients at risk of #bipolardisorder? This was controversial among Grand Rounds attendees. Want to hear what experts said? Dr Cutler walks through his and 4 other experts’ thoughts in this program archive. Link: bit.ly/3TaFJdq

With the CMS expanding coverage for amyloid PET in #AlzheimersDisease, it is now more important than ever to have radiologists who are experienced with amyloid therapies. Join us at #RSNA2023 as we talk through critical roles of #radiology. Learn more: lnkd.in/eNfQDuCQ

#MyastheniaGravis long had a reputation as “one of the best understood autoimmune diseases” where patients can live “near-normal lives” once treated. But a survey of 109 patients found that this is not the case. See behind closed doors in, “Inside MG": lnkd.in/ensAFTff

New DMTs for #Alzheimers mean new adverse effects. See how experts think about ARIA and get a crash course for your specialty. Intro: bit.ly/ARIAIntro Neuro: bit.ly/NeuroARIA PCP: bit.ly/PCPARIA Emed: bit.ly/EmergencyARIA Rad: bit.ly/RadiologyARIA

Spasticity is an unyielding symptom for ~80% of patients with #MS. Yet nearly 50% of surveyed patients reported that MS clinicians only ask about it “every so often” or not at all. Experts address this and more in our program, "Overburdened, Undertreated": lnkd.in/eNeWwTqb

Clinicians asked, faculty (and audience) answered! Thank you to the neurologists who asked fantastic questions for our #NMOSD symposium at #CMSC2023; and to Drs Shin, Graves, and Weinshenker for helping to think through them. Keep an eye out for the archive. See you next time!

Wondering what colleagues are asking about NMOSD? Find out at #CMSC2023! In this symposium, neurologists who treat #NMOSD (and #MOGAD) will voice real questions about their challenges. Experts will address these and other optimal strategies. Learn more: lnkd.in/diaZ3jGM

New therapies have changed #SMA from causal of infant death to compatible with life into adulthood. This new paradigm enlists adult clinicians who once had little role. We invited experts of child and adult care to explore cases in the new SMA. Link: lnkd.in/ezhYZtZe

Thank you to everyone who made our 2 programs at the #ACTRIMS2023 Forum a success. Didn’t make it to San Diego? Still eager to hear about changes in NMOSD? Still wondering what Dr Shin is talking about with those dots? Stay tuned for enduring versions at: activities.efficientcme.com.

Monitoring strategies in MS are critical due to potential worsening between relapses. But what about in #NMOSD which is thought to only worsen with relapse? See answers from 25 experts at our #ACTRIMS2023 satellite, “A Deeper Look at NMOSD.” Learn more: lnkd.in/e29pTg8s

As a preview for one of our two upcoming satellite symposia at #ACTRIMS2023, we wanted to provide a teaser of one of Dr Shin’s slides on #multiplesclerosis. What is Dr Shin talking about? Find out February 23rd in Battle of the Biomarkers. Learn more: lnkd.in/gQ2mA5vX

Do you think like the top minds in #NMOSD? We surveyed 25 specialists on how they practice in the evolving age of care. See where they trend, where they diverge, and how you compare in our 1-hour lunch-time symposium at #ACTRIMS2023. Learn more: lnkd.in/e29pTg8s

In #CME, we try to highlight where experts agree. But what happens when they don’t? This #ACTRIMSForum, we’re giving the stage to concepts that lack consensus, allowing leaders in the field to present their views on complex issues in #MS Learn more at: lnkd.in/gQ2mA5vX

Attending #AES2022? Kick it off with our 90min dinner symposium. Experts will introduce thought-provoking considerations regarding the role of genetics in epilepsy and provide a sneak-peak into the not-so-distant future of precision medicine. Learn more: lnkd.in/dSWqGHDi

If CME is meeting clinician needs, educational gaps should be constantly changing. At Efficient, we try to stay on top of this with our provider assessments. For example, managing inactive MS is a hot topic today. But is this issue important for education? Survey says, you bet!

Depression is one of the most common mental health conditions. But what if it’s not actually major depressive disorder? Explore when to suspect #bipolardisorder and more in this virtual Grand Rounds series. To host, email [email protected] or visit lnkd.in/exahC4y3

With most medications, “treatment failure” is straightforward. But with botulinum toxin (BoNT) for spasticity or dystonia, it’s not so simple. In fact, the patient may not be failing at all. Learn all the nuances of BoNT success in, Unlocking Movement: lnkd.in/eMprhREe